Experimental (tamoxifen-induced) manipulation of female reproduction in zebra finches (Taeniopygia guttata).
Experimental manipulation of reproductive phenotype is a potentially powerful approach for understanding the fitness relationships of traits such as egg size, egg composition, and egg number. In this study, I investigated the effect of the antiestrogen tamoxifen on multiple, estrogen-dependent reproductive traits in female zebra finches (Taeniopygia guttata). Short-term tamoxifen treatment of egg-laying females (two daily injections before laying) had no effect on the timing or the pattern of egg laying compared to sham controls. However, tamoxifen treatment caused (1) a marked, but transient, decrease in egg size; (2) increased within-clutch egg-size variation; (3) a reduction in plasma vitellogenin (VTG) levels; and (4) lower dry yolk and yolk protein content of tamoxifen-treated females. Plasma levels of the second yolk precursor, very low density lipoprotein (VLDL), were not affected by tamoxifen, and tamoxifen appeared to have no effect on oviduct function in egg-laying females. These results are consistent with tamoxifen blocking estrogen receptors in the liver, suppressing VTG production, and decreasing the plasma pool of yolk precursors below a level required to maintain yolk formation at the normal rate. Tamoxifen treatment can therefore be used successfully to manipulate several components of the female reproductive phenotype (egg composition, intraclutch egg-size variation) to further explore the fitness consequences of these traits.
Williams
T D
TD
Department of Biological Sciences, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada. tdwillia@sfu.ca
D000818:Animals; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D010641:Phenotype; D011960:Receptors, Estrogen / Q000187:drug effects / Q000502:physiology; D012098:Reproduction / Q000187:drug effects*; D012641:Selection, Genetic; D020308:Songbirds / Q000502:physiology*; D013629:Tamoxifen / Q000494:pharmacology*; D014819:Vitellogenins / Q000097:blood
D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D014819:Vitellogenins; D013629:Tamoxifen